NCT05896852

Brief Summary

This study is being done to understand how a physical activity walking intervention affects metabolic parameters (i.e., blood sugar, cholesterol, certain body measurements) in people with and without HIV. This study involves a physical activity intervention where participants will progressively increase activity as tolerated over a six month period.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Oct 2023Oct 2026

First Submitted

Initial submission to the registry

May 11, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 9, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

October 21, 2025

Status Verified

October 1, 2025

Enrollment Period

2.8 years

First QC Date

May 11, 2023

Last Update Submit

October 17, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Acceptability of Study Activities (Recruitment)

    To determine acceptability of study activities investigators will determine overall recruitment and determine percentage of the target recruitment that enrolled in the study at the 6 month study completion point (goal = 90% of our target).

    6 months

  • Acceptability of Study Activities (Attrition)

    Investigators will measure attrition by determination of the number of participants who complete all study visits (measured by total number of participants who complete the baseline, 3-month, and 6-month study visits - goal \>75%). These will be assessed at the end of the 6-month study period.

    6 months

  • Adherence to Study Activities of Study Activities

    Investigators will determine adherence to study activities by determination of the completion of study visits, completion of laboratory testing at study visits, and completion of step counting journals. Investigators will assess total number of documented study visits, completion of laboratory testing, and assessment of total number of days steps were entered in step logs. Investigators will assess the total number of visits, laboratory blood draws, and entries in to step log at each visit and determine overall percentage completed.

    6 months

Secondary Outcomes (6)

  • Metabolic Parameters (Laboratory Measurement - blood glucose)

    6 months

  • Metabolic Parameters (Laboratory Measurement - lipids)

    6 months

  • Metabolic Parameters (Laboratory Measurement - HBA1c)

    6 months

  • Body Composition (Waist Circumference [cm])

    6 months

  • Body Composition (BMI [kg/m^2])

    6 months

  • +1 more secondary outcomes

Study Arms (1)

Intervention Arm

EXPERIMENTAL

Participants will increase their physical activity over 6 months as tolerated,

Behavioral: physical activity

Interventions

Participants will increase their physical activity through walking.

Intervention Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18
  • Persons living with or without HIV
  • Metabolic Syndrome or risk factors for metabolic syndrome with BMI \>=30
  • Able to provide informed consent
  • No physical limitations that prevent walking for more than 10 minutes
  • Can provide evidence of medical clearance by healthcare provider, if required before or during the study

You may not qualify if:

  • Currently exercising regularly (at least 2x weekly of at least 20minutes of moderate or vigorous activity)
  • Current enrollment in another physician activity and/or dietary clinical trial or on diet/weight-loss program
  • Active plans for bariatric surgery
  • Inability to commit to the intervention schedule
  • Not eligible as per screening form
  • Currently pregnant or planning to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Georgetown University

Washington D.C., District of Columbia, 20007, United States

Location

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Exercise

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
N/A all study participants will be included in the intervention arm.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2023

First Posted

June 9, 2023

Study Start

October 1, 2023

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

October 21, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations